Hao Yu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Muscle Invasive Bladder Cancer

Immune Response

Long Non Coding Rna

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Wang, Bingkun Zhou, Junyu Chen, Xi Sun, Wenjuan Yang, Tenghao Yang, Hao Yu, Peng Chen, Ke Chen, Xiaodong Huang, Xinxiang Fan, Wang He, Jian Huang, Tianxin Lin
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for immunotherapy of cancer 12 (4) (2024)
Bo Wang, Bingkun Zhou, Junyu Chen, Xi Sun, Wenjuan Yang, Tenghao Yang, Hao Yu, Peng Chen, Ke Chen, Xiaodong Huang, Xinxiang Fan, Wang He, Jian Huang, Tianxin Lin
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for immunotherapy of cancer 12 (4) (2024)
Meihua Yang, Bo Wang, Weibin Hou, Honghui Zeng, Wang He, Xin-Ke Zhang, Dong Yan, Hao Yu, Long Huang, Lu Pei, Kaiwen Li, Haide Qin, Tianxin Lin, Jian Huang
NAD + metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Meihua Yang, Bo Wang, Weibin Hou, Honghui Zeng, Wang He, Xin-Ke Zhang, Dong Yan, Hao Yu, Long Huang, Lu Pei, Kaiwen Li, Haide Qin, Tianxin Lin, Jian Huang
NAD + metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Bo Wang, Bingkun Zhou, Junyu Chen, Xi Sun, Wenjuan Yang, Tenghao Yang, Hao Yu, Peng Chen, Ke Chen, Xiaodong Huang, Xinxiang Fan, Wang He, Jian Huang, Tianxin Lin
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for immunotherapy of cancer 12 (4) (2024)
Bo Wang, Bingkun Zhou, Junyu Chen, Xi Sun, Wenjuan Yang, Tenghao Yang, Hao Yu, Peng Chen, Ke Chen, Xiaodong Huang, Xinxiang Fan, Wang He, Jian Huang, Tianxin Lin
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for immunotherapy of cancer 12 (4) (2024)
Meihua Yang, Bo Wang, Weibin Hou, Honghui Zeng, Wang He, Xin-Ke Zhang, Dong Yan, Hao Yu, Long Huang, Lu Pei, Kaiwen Li, Haide Qin, Tianxin Lin, Jian Huang
NAD + metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Bo Wang, Bingkun Zhou, Junyu Chen, Xi Sun, Wenjuan Yang, Tenghao Yang, Hao Yu, Peng Chen, Ke Chen, Xiaodong Huang, Xinxiang Fan, Wang He, Jian Huang, Tianxin Lin
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses. Journal for immunotherapy of cancer 12 (4) (2024)